Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Milan - Delayed Quote • EUR Walgreens Boots Alliance, Inc. (1WBA.MI) Follow Add holdings 9.64 -0.03 (-0.27%) At close: May 2 at 2:55:57 PM GMT+2 All News Press Releases SEC Filings Walgreens Boots Alliance (WBA) Increases Yet Falls Behind Market: What Investors Need to Know Walgreens Boots Alliance (WBA) reachead $10.98 at the closing of the latest trading day, reflecting a +0.46% change compared to its last close. Private Credit’s Cracks Widened Before Turmoil (Bloomberg) -- The companies that get private credit loans are looking increasingly wobbly and banks are among those that could eventually be on the hook for losses.Most Read from BloombergWhy Car YouTuber Matt Farah Is Fighting for Walkable CitiesNewsom Says California Is Now the World’s Fourth-Biggest EconomyAt Bryn Mawr, a Monumental Plaza Traces the Steps of Black HistoryBackyard Micro-Flats Aim to Ease South Africa’s Housing CrisisLos Angeles Downgraded to AA- by S&P Due to Budget WoesMany Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day Saturday, April 26, 2025 DEERFIELD, Ill., April 25, 2025--Walgreens is calling on the public to help in the fight against prescription drug abuse by participating in National Prescription Drug Take Back Day on Saturday, April 26th, 2025. Drug take-back days are reserved annually for the safe disposal of unwanted, unused, or expired medications. Walgreens has more than 1,500 kiosks across 46 states and Washington, D.C. These kiosks are a convenient way to ensure medications are not accidentally or intentionally misused. Tractor Supply (TSCO) To Report Earnings Tomorrow: Here Is What To Expect Rural goods retailer Tractor Supply (NASDAQ:TSCO) will be reporting results tomorrow before the bell. Here’s what investors should know. Walgreens reaches $300m deal over opioid prescriptions claims The retailer will pay an extra $50m to the US Government if it undergoes a sale, merger, or transfer prior to 2032. Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline DEERFIELD, Ill., April 23, 2025--Walgreens, the nation’s largest independent community pharmacy provider, has teamed up with Guild, the leading talent development company, to launch PharmStart, a first-of-its-kind, fully funded online education program designed to help eligible team members meet the prerequisite requirements for pharmacy school. The program aims to eliminate barriers to pursuing a PharmD degree, tapping into a new pool of talent while also addressing critical challenges in the p Jim Cramer on Walgreens (WBA): “Clock’s Ticking on That One” We recently published a list of Jim Cramer Reveals Where Investors Fled During Tariff Selloff & Discusses 10 Stocks. In this article, we are going to take a look at where Walgreens Boots Alliance, Inc. (NASDAQ:WBA) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s Squawk on the Street, Jim […] Walgreens agrees to pay over $300M to settle False Claims Act suit Walgreens agreed to pay the United States $300M, plus interest at a rate of 4.00% per annum accruing from October 20, 2024, of which $150M shall constitute restitution, to resolve False Claims Act allegations. Th settlement is neither an admission of liability by Walgreens nor a concession by the United States that its claims are not well founded, according to a court filing. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today Walgreens to pay up to $350M in DOJ opioid settlement The Justice Department alleged the pharmacy chain knowingly provided prescriptions for large amounts of opioids, filled prescriptions early and completed prescriptions for a dangerous combination of drugs. Walgreens to pay up to $350 million in U.S. opioid settlement Walgreens has agreed to pay up to $350 million in a settlement with the U.S. Department of Justice, which said that it illegally filling millions of prescriptions in the last decade for opioids and other controlled substances. The nationwide drugstore chain must pay the government at least $300 million and will owe another $50 million if the company is sold, merged, or transferred before 2032, according to the settlement reached last Friday. The government’s complaint, filed in January in the U.S. District Court for the Northern District of Illinois, alleges that Walgreens knowingly filled millions of illegal prescriptions for controlled substances between August 2012 and March 2023. Sector Update: Health Care Stocks Retreat Late Afternoon Health care stocks fell late Monday afternoon with the NYSE Health Care Index down 2.4% and the Heal Update: Walgreens to Pay Up to $350 Million to Settle Claims It Played a Role in the US Opioid Crisis (Updates with Walgreens' response.) Walgreens Boots Alliance (WBA) has agreed to pay up to $350 m Walgreens to Pay Up to $350 Million to Settle Claims It Played a Role in the US Opioid Crisis Walgreens Boots Alliance (WBA) has agreed to pay up to $350 million to settle claims it played a rol Walgreens to pay $300 million in US opioid settlement Walgreens will also owe the U.S. an additional $50 million if the company is sold, merged, or transferred prior to fiscal year 2032, the Justice Department said. "We strongly disagree with the government’s legal theory and admit no liability," Walgreens spokesperson Fraser Engerman said in a statement. Walgreens Boots Alliance (WBA): Strong Industry, Solid Earnings Estimate Revisions Walgreens Boots Alliance (WBA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. Down 89%, Should You Buy the Dip on Walgreens Boots Alliance? Investors could profit up to 36% from the stock's current share price, but there are risks. Seeking Income? 3 High Yield Stocks Worth a Look Dividend-paying stocks can allow investors to build a cash pile quickly. After all, isn't payday the best? Walgreens Boots Alliance sees net loss narrowed in Q2 FY25 WBA has retracted fiscal guidance for 2025, given its impending divesture to Sycamore Partners. Walgreens Beats on Q2 Earnings, Withdraws Fiscal 2025 View, Stock Down WBA delivers better-than-expected earnings and revenues in the second quarter of fiscal 2025. Tariffs Won't Stop Walgreens Buyout, Barclays Says Walgreens Boots Alliance’s leveraged buyout by Sycamore Partners will likely go ahead in the fourth quarter despite market turmoil from new U.S. tariffs, according to bond analysts at Barclays. Sycamore pulled out of its proposed buyout of Victoria’s Secret owner L Brands in 2020, arguing that the pandemic triggered a “material adverse change,” or MAC, clause in its purchase agreement. The MAC clause in the Walgreens deal excludes political conditions or changes and “we don’t see a clear out due to current market disruption,” Barclays analysts said Tuesday. Performance Overview Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) Return 1WBA.MI S&P 500 (^GSPC) YTD +6.62% -3.31% 1-Year -36.71% +12.29% 3-Year -51.11% +36.85%